Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons
I give below details of changes in the interests of Directors, Persons Discharging Managerial Responsibility or Connected Persons in the Ordinary Shares of GlaxoSmithKline plc in respect of the under-mentioned persons arising from the purchase of Ordinary Shares at a price of 1460.066 pence per Ordinary Share on 4 October 2012 as a result of the reinvestment of dividends paid on Ordinary Shares held in the GlaxoSmithKline ShareReward Plan (the Plan).
Sir Andrew Witty |
Acquisition of 24 Ordinary Shares
|
Mr S M Bicknell |
Acquisition of 13 Ordinary Shares
|
Mr R G Connor |
Acquisition of 28 Ordinary Shares
|
Mr S Dingemans |
Acquisition of 3 Ordinary Shares
|
Mr S A Hussain |
Acquisition of 7 Ordinary Shares
|
Dr D Pulman |
Acquisition of 11 Ordinary Shares
|
Mr D S Redfern |
Acquisition of 13 Ordinary Shares
|
Ms C Thomas |
Acquisition of 13 Ordinary Shares
|
Mr P C Thomson |
Acquisition of 16 Ordinary Shares
|
Dr P J T Vallance |
Acquisition of 17 Ordinary Shares |
Mrs V A Whyte |
Acquisition of 22 Ordinary Shares |
The Company and the above-mentioned persons were advised of this information on
5 October 2012.
This notification relates to a transaction notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).
V A Whyte
Company Secretary
5 October 2012